Your browser doesn't support javascript.
loading
Prediction of early death among patients enrolled in phase I trials: development and validation of a new model based on platelet count and albumin.
Ploquin, A; Olmos, D; Lacombe, D; A'Hern, R; Duhamel, A; Twelves, C; Marsoni, S; Morales-Barrera, R; Soria, J-C; Verweij, J; Voest, E E; Schöffski, P; Schellens, J H; Kramar, A; Kristeleit, R S; Arkenau, H-T; Kaye, S B; Penel, N.
Affiliation
  • Ploquin A; Centre Oscar Lambret, Medical Oncology Department, 3 rue Combemale, Lille 59020, France.
Br J Cancer ; 107(7): 1025-30, 2012 Sep 25.
Article in En | MEDLINE | ID: mdl-22910320

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Platelet Count / Serum Albumin / Models, Statistical / Clinical Trials, Phase I as Topic / Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Br J Cancer Year: 2012 Document type: Article Affiliation country: France Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Platelet Count / Serum Albumin / Models, Statistical / Clinical Trials, Phase I as Topic / Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Br J Cancer Year: 2012 Document type: Article Affiliation country: France Country of publication: United kingdom